About AlternaFuel® CMAX3™
AlternaFuel® CMAX3™ is the latest generation of a cellulase and hemicellulase complex based on Dyadic's C1 platform technology which enables efficient conversion of multiple forms of non-food biomass into fermentable sugars at broad pH and temperature ranges that can be used to produce biofuels, bio-based chemicals, biogas and other bio-based products.
For more information on AlternaFuel® CMAX3™, please visit Dyadic's recently remodeled website at www.dyadic.com.
Dyadic International, Inc. is a global biotechnology company that uses its patented and proprietary C1 fungal production platform and other technologies to conduct research, development and commercial activities for the discovery, development, manufacture and sale of enzymes and others proteins for the bioenergy, industrial enzyme and biopharmaceutical industries.
Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the proteins which these technologies help produce.
Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, The Netherlands that conducts research and development activities for the benefit of Dyadic, its collaborators and customers. Please visit Dyadic Netherland's website at www.dyadic.nl.
Cautionary Statement for Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements. These forward-looking stateme
|SOURCE Dyadic International, Inc.|
Copyright©2012 PR Newswire.
All rights reserved